DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Bassetti MF, Turk AA, Lubner SJ. et al.
A phase Ib study of pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver metastatic MSS colorectal cancer (CRC): a postoperative safety analysis.
J Clin Oncol 2019;
37: e15047 .
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e15047
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.